Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Apr;39(4):414–421. doi: 10.1038/bjc.1979.74

Retrovirus-like particles in EBV-negative Burkitt's lymphoma cell line but not in EBV-DNA-positive lines from patients with ataxia telangiectasia and Down's syndrome.

M Kotler, H Balabanova, A Friedmann, Y Becker
PMCID: PMC2009919  PMID: 220999

Abstract

Retrovirus-like particles can be recovered by arginine deprivation from the BJAB-1 Epstein-Barr virus (EBV) negative cell line derived from an African patient with typical Burkitt's lymphoma. These particles resemble retroviruses in their morphology and in their physicochemical properties. Particles with a similar morphology were obtained from derivative cell lines established by infecting BJAB-1 cells with EBV. On the other hand, retrovirus-like particles could not be induced in EBV-DNA-positive lymphoblastoid cell lines derived from non-leukaemic patients with ataxia telangiectasia and Down's syndrome and from a patient with infectious mononucleosis.

Full text

PDF
414

Images in this article

418Fig. 2
on p.418
419Fig. 3
on p.419
419Fig. 4
on p.419

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chopra H. C., Hooks J. J., Walling M. J., Gibbs C. J., Jr Morphology of simian foamy viruses, with particular reference to virus isolated from spontaneous tumor of a rhesus monkey. J Natl Cancer Inst. 1972 Feb;48(2):451–463. [PubMed] [Google Scholar]
  2. Clements G. B., Klein G., Povey S. Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. Int J Cancer. 1975 Jul 15;16(1):125–133. doi: 10.1002/ijc.2910160114. [DOI] [PubMed] [Google Scholar]
  3. Gallagher R. E., Gallo R. C. Type C RNA tumor virus isolated from cultured human acute myelogenous leukemia cells. Science. 1975 Jan 31;187(4174):350–353. doi: 10.1126/science.46123. [DOI] [PubMed] [Google Scholar]
  4. Gelderblom H., Bauer H., Ogura H., Wigand R., Fischer A. B. Detection of oncornavirus-like particles in HeLa cells. I. Fine structure and comparative morphological classification. Int J Cancer. 1974 Feb 15;13(2):246–253. doi: 10.1002/ijc.2910130212. [DOI] [PubMed] [Google Scholar]
  5. Klein G., Giovanella B., Westman A., Stehlin J. S., Mumford D. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology. 1975;5(6):319–334. doi: 10.1159/000149930. [DOI] [PubMed] [Google Scholar]
  6. Klucis E., Jackson L., Parsons P. G. Survey of human lymphoblastoid cell lines and primary cultures of normal and leukaemic leukocytes for oncornavirus production. Int J Cancer. 1976 Oct 15;18(4):413–420. doi: 10.1002/ijc.2910180404. [DOI] [PubMed] [Google Scholar]
  7. Kotler M., Balabanova H., Ben-Moyal Z., Friedman A., Becker Y. Properties of the oncornavirus particles isolated from P3HR-1 and Raji human lymphoblastoid cell lines. Isr J Med Sci. 1977 Jul;13(7):740–746. [PubMed] [Google Scholar]
  8. Kotler M., Balabanova H., Weinberg E., Friedmann A., Becker Y. Oncornavirus-like particles released from arginine-deprived human lymphoblastoid cell lines. Proc Natl Acad Sci U S A. 1975 Nov;72(11):4592–4596. doi: 10.1073/pnas.72.11.4592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kotler M., Weinberg E., Haspel O., Olshevsky U., Becker Y. Particles released from arginine deprived human leukaemic cells. Nat New Biol. 1973 Aug 15;244(137):197–200. doi: 10.1038/newbio244197a0. [DOI] [PubMed] [Google Scholar]
  10. Mak T. W., Manaster J., Howatson A. F., McCulloch E. A., Till J. E. Particles with characteristics of leukoviruses in cultures of marrow cells from leukemic patients in remission and relapse. Proc Natl Acad Sci U S A. 1974 Nov;71(11):4336–4340. doi: 10.1073/pnas.71.11.4336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Menezes J., Leibold W., Klein G., Clements G. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine. 1975 Jul;22(4):276–284. [PubMed] [Google Scholar]
  12. Miller G., Shope T., Lisco H., Stitt D., Lipman M. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc Natl Acad Sci U S A. 1972 Feb;69(2):383–387. doi: 10.1073/pnas.69.2.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nooter K., Aarssen A. M., Bentvelzen P., De Groot F. G., Van Pelt F. G. Isolation of infectious C-type oncornavirus from human leukaemic bone marrow cells. Nature. 1975 Aug 14;256(5518):595–597. doi: 10.1038/256595a0. [DOI] [PubMed] [Google Scholar]
  14. Popovic M., Ponten J., Grofovå M., Nilsson K., Matoska J. Detection of oncornavirus-like particles in human cell lines derived from tumours of hemopoietic tissue. Neoplasma. 1974;21(6):619–627. [PubMed] [Google Scholar]
  15. Smith C. C., Maverakis N. H., Ackermann W. W. Characterization of extracellular particles released from continuous cell cultures derived from human leukemia. Proc Soc Exp Biol Med. 1976 Sep;152(4):645–650. doi: 10.3181/00379727-152-39459. [DOI] [PubMed] [Google Scholar]
  16. Steinitz M., Klein G. Comparison between growth characteristics of an Epstein--Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3518–3520. doi: 10.1073/pnas.72.9.3518. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES